Loading…

Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019

A 42-year-old man exhibiting hypoxia was diagnosed with coronavirus disease 2019. He had medical histories of type 2 diabetes, hyperlipidemia, hyperuricemia, and gout attack. He received favipiravir for compassionate use for 14 days. Subsequently, he showed increased uric acid levels and developed a...

Full description

Saved in:
Bibliographic Details
Published in:Internal Medicine 2020/09/15, Vol.59(18), pp.2327-2329
Main Authors: Hase, Ryota, Kurata, Rika, Ishida, Keiko, Kurita, Takashi, Muranaka, Emiri, Mito, Haruki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 42-year-old man exhibiting hypoxia was diagnosed with coronavirus disease 2019. He had medical histories of type 2 diabetes, hyperlipidemia, hyperuricemia, and gout attack. He received favipiravir for compassionate use for 14 days. Subsequently, he showed increased uric acid levels and developed acute gouty arthritis. Favipiravir may induce not only hyperuricemia but also acute gouty arthritis. It should therefore be used with caution in patients with a history of gout and those with hyperuricemia, especially when used at a higher dose and for a longer duration than is typical.
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.5377-20